Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
J Cell Biochem ; 103(3): 1005-12, 2008 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-17647273

RESUMO

We have previously shown that transcription of immediate-early c-fos protooncogene is becoming strongly repressed in rat embryo fibroblasts transformed by oncogenes E1A and cHa-ras, so that serum only slightly stimulated c-fos transcription in these cells in contrast to high level of c-fos activation in non-transformed REF52 cells. Here we showed that stress-inducing agent anisomycin was able to override the c-fos repression and to induce c-fos transcription in E1A + ras transformants. In vitro kinase assay data demonstrated that anisomycin increased phosphorylation of transactivation domain of Elk-1 transcription factor--a key regulator of inducible c-fos transcription. Importantly, this activation was mediated through up-regulation of MEK/ERK but not stress-kinase cascades JNK or p38. The activating effect of anisomycin on c-fos transcription could be abrogated by a prior treatment with N-acetyl-L-cysteine. This indicates that anisomycin potentiates generation of reactive oxygen species (ROS), which, in turn, can modulate the activity of MAP kinase-specific phosphatases (MKPs). As anisomycin did not cause acetylation of nucleosome core histones, the present work focuses on the molecular mechanisms mediating the HDAC-independent induction of IEG c-fos by anisomycin in E1A + cHa-ras-transformed fibroblasts.


Assuntos
Proteínas E1A de Adenovirus/biossíntese , Anisomicina/farmacologia , Transformação Celular Neoplásica/metabolismo , Genes fos/efeitos dos fármacos , Proteínas Imediatamente Precoces/metabolismo , Sistema de Sinalização das MAP Quinases/genética , Proteínas Proto-Oncogênicas c-fos/sangue , Animais , Linhagem Celular Transformada , Transformação Celular Neoplásica/genética , Ativação Enzimática , Regulação Neoplásica da Expressão Gênica , Inativação Gênica/efeitos dos fármacos , Inativação Gênica/fisiologia , Genes ras/efeitos dos fármacos , Proteínas Imediatamente Precoces/genética , Proteínas Quinases Ativadas por Mitógeno , Fosforilação , Ratos , Ativação Transcricional/efeitos dos fármacos , Proteínas Elk-1 do Domínio ets/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA